AbbVie Newsroom

Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $212

Futu News18:32

AbbVie Price Target Raised to $226.00/Share From $215.00 by Citigroup

Dow Jones04:41

AbbVie Is Maintained at Buy by Citigroup

Dow Jones04:41

UBS Adjusts Price Target on AbbVie to $200 From $195, Maintains Neutral Rating

MT NewswiresOct 31 23:15

Cantor Fitzgerald Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $240

Futu NewsOct 31 21:31

A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $205 to $240

Futu NewsOct 31 21:19

AbbVie Analyst Ratings

BenzingaOct 31 20:52

Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $231

BenzingaOct 31 20:52

Evercore ISI Adjusts Price Target on AbbVie to $204 From $192

MT NewswiresOct 31 01:57

Leerink Partners Maintains AbbVie(ABBV.US) With Hold Rating

Futu NewsOct 29 20:32

AbbVie Is Maintained at Buy by Citigroup

Dow JonesOct 26 02:33

AbbVie Analyst Ratings

BenzingaOct 26 02:23

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $209

Futu NewsOct 23 20:31

AbbVie (ABBV) Gets a Buy From Piper Sandler

TipRanksOct 23 19:46

Leerink Partners Maintains AbbVie(ABBV.US) With Hold Rating, Announces Target Price $206

Futu NewsOct 23 15:33

AbbVie: Balanced Outlook Amid EPS Adjustments and Pipeline Uncertainties Warrants Hold Rating

TipRanksOct 23 14:47

Goldman Sachs Adjusts Price Target on AbbVie to $208 From $200

MT NewswiresOct 21 20:19

AbbVie Price Target Raised to $195.00/Share From $185.00 by B of A Securities

Dow JonesOct 19 01:37

AbbVie Analyst Ratings

BenzingaOct 19 01:29

BofA Securities Initiates AbbVie(ABBV.US) With Hold Rating

Futu NewsOct 18 21:34